A practical evidence-based application for the Oncologists which helps the decision making about antiemetic prophylaxis
Lugano, Switzerland, March 17th 2014- (PressReleasePoint) - Emesis Guide is an application designed as a practical tool for the Oncologists, aimed at facilitating the decision making on the antiemetic therapy to be administered to patients undergoing a specific chemotherapy regimen.
A large proportion of cancer patients still suffer from chemotherapy-induced nausea and vomiting (CINV), with negative consequences on compliance, health status and quality of life. It is therefore very important to optimize CINV prophylaxis with the most appropriate antiemetic schedule.
Emesis Guide contributes to speed up the decision making about antiemetic prophylaxis.
It is an evidence-based application. HANDY - free app designed for your smartphone or tablet USEFUL - information on the emetic risk of single agents and combination chemotherapy regimens UPDATED - with data from the latest international guidelines
The app is supported by an unrestricted grant from Helsinn Healthcare S.A..
Watch the app presentation on Videum and learn more at emesisguide.com. Download Emesis Guide now on App Store, Google Play.
International Antiemetic Guidelines
Information included is based on developed and regularly updated evidence-based guidelines for the use of antiemetics in the oncology settings from ASCO, ESMO, MASCC, NCCN and NCI guidelines, and it has been integrated with relevant evidences from the international scientific literature.
It’s possible to find complete information about Antiemetic Guidelines in the following: MASCC/ESMO Antiemetic Guidelines
Roila F, Herrstedt J, Aapro M, et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 2010; 21 [suppl 5]:v232-v243 Antiemetics: ASCO Clinical Practice Guideline Update
Basch E, et al, Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update, J Clin Oncol Nov 1, 2011:398-401 NCCN Clinical Practice Guidelines in Oncology
Version I.2013 www.ncccn.org
Please note that the Emesis Guide should only be used as a guide for decisions about antiemetic prophylaxis, and it’s not a tool for the selection of anticancer therapy. This application is intended for non-US physicians only.
Press Contact: Fabiana D’Alvia Via Amato 0893061486 http://emesisguide.com/ *******.*******@*a**r**s**e**t**a**.com Email partially hidden to block spam. Please use the contact form here.